Skip to main content

Filter content

October 23, 2020
A new collaborative fund backed by an investment and incubation company created by Melinda Gates has been created to boost mental healthcare for minority and/or LGBTQ+ adolescents in the United States, particularly in the midst of the COVID-19 pandemic.
October 23, 2020
For many individuals in recovery, re-entering the workforce is a crucial component of maintaining wellness. In West Virginia, Creating Opportunity for Recovery Employment (CORE), a program within the Addiction Sciences division at the Marshall University Joan C. Edwards School of Medicine, aims not…
October 22, 2020
Heroic Hearts Project, a not-for-profit that connects military veterans who are struggling with mental trauma to psychedelic therapies, and Field Trip Health, a technology-enabled psychedelic therapies provider, have announced a partnership to boost access to and awareness of psychedelic therapies…
October 22, 2020
In this video from Psych Congress 2020, Sanjai Rao, MD, discusses whether imaging data could play a role in diagnosing schizophrenia.
October 22, 2020
Universal Health Services this week announced that Mark Friedlander, MD, MBA, is joining the organization as the new chief medical officer for its Behavioral Health Division. Friedman is a board-certified, practicing psychiatrist, and as CMO, he will be tasked with helping to develop the overall…
October 22, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD).
October 21, 2020
Students diagnosed with depression undergo a drop in educational performance around ages 15 and 16 years, and boys and students from deprived backgrounds may be especially vulnerable, a study shows.
October 21, 2020
The Foundation for Opioid Response Efforts (FORE) has announced it will provide more than $634,000 in grants to 10 organizations to help at-risk populations that are struggling with increases in opioid use and overdoses during the COVID-19 pandemic. This is the second wave of grants distributed by…
Q&A
October 21, 2020
Laura J. Fochtmann, MD, MBI, shares insights on a new set of evidence-based practice guidelines for the treatment of patients with schizophrenia, which she helped write.
Back to Top